​

Thermo Fisher Scientific (TMO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TMO Stock Forecast

Thermo Fisher Scientific (TMO) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $592.00, with a high of $693.00 and a low of $460.00. This represents a 22.07% increase from the last price of $484.96.

$450 $500 $550 $600 $650 $700 High: $693 Avg: $592 Low: $460 Last Closed Price: $484.96

TMO Stock Rating

Thermo Fisher Scientific stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 34 Buy (82.93%), 7 Hold (17.07%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 7 34 0 Strong Sell Sell Hold Buy Strong Buy

TMO Price Target Upside V Benchmarks

TypeNameUpside
StockThermo Fisher Scientific22.07%
SectorHealthcare Stocks 18.80%
IndustryDiagnostics & Research Stocks14.86%

Price Target Trends

1M3M12M
# Anlaysts1113
Avg Price Target$460.00$460.00$619.38
Last Closing Price$484.96$484.96$484.96
Upside/Downside-5.15%-5.15%27.72%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 256186--30
Jun, 257186--31
May, 257186--31
Apr, 258176--31
Mar, 258186--32
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 08, 2025Dan LeonardUBS$460.00$426.177.94%-5.15%
Apr 25, 2025Scotiabank$605.00$424.2442.61%24.75%
Apr 23, 2025Matthew SykesGoldman Sachs$610.00$431.6441.32%25.78%
Jan 31, 2025Conor McNamaraRBC Capital$693.00$597.7515.93%42.90%
Jan 02, 2025Vijay KumarEvercore ISI$585.00$522.5711.95%20.63%
Oct 24, 2024Catherine SchulteRobert W. Baird$622.00$576.497.89%28.26%
Oct 23, 2024Luke SergottBarclays$610.00$570.926.85%25.78%
Oct 01, 2024Vijay KumarEvercore ISI$630.00$618.571.85%29.91%
Sep 20, 2024Daniel AriasStifel Nicolaus$680.00$620.259.63%40.22%
Sep 20, 2024Catherine SchulteRobert W. Baird$632.00$620.251.89%30.32%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 11, 2025ScotiabankSector PerformOutperformupgrade
Jul 08, 2025UBSNeutraldowngrade
Apr 23, 2025Goldman SachsBuyBuyhold
Mar 06, 2025Goldman SachsReduceReducehold
Feb 03, 2025ScotiabankSector PerformSector Performhold
Jan 31, 2025Morgan StanleyOverweightOverweighthold
Jan 31, 2025BernsteinOutperformOutperformhold
Jan 31, 2025RBC CapitalOutperformOutperformhold
Jan 10, 2025BernsteinOutperformupgrade
Jan 02, 2025Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$15 $19 $23 $27 $31 $35 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.10$19.61$17.73$15.53$16.58----
Avg Forecast$19.03$23.54$23.04$21.52$21.70$23.08$25.67$29.52$32.82
High Forecast$19.36$23.96$23.37$21.60$21.76$23.92$27.20$31.42$33.37
Low Forecast$18.73$23.17$22.59$21.50$21.48$22.59$22.97$27.63$32.22
Surprise %-15.40%-16.69%-23.05%-27.83%-23.59%----

Revenue Forecast

$30B $35B $40B $45B $50B $55B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$32.22B$39.21B$44.91B$42.86B$42.88B----
Avg Forecast$31.12B$37.26B$43.88B$42.75B$42.77B$44.51B$47.71B$51.15B$53.89B
High Forecast$31.54B$37.76B$44.37B$42.79B$42.88B$44.75B$47.79B$51.44B$54.59B
Low Forecast$30.74B$36.80B$43.22B$42.72B$42.60B$44.08B$47.63B$50.86B$53.14B
Surprise %3.53%5.24%2.36%0.25%0.25%----

Net Income Forecast

$4B $5B $7B $9B $11B $13B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.38B$7.72B$6.95B$6.00B$6.33B----
Avg Forecast$5.38B$9.13B$4.70B$6.00B$8.39B$9.02B$9.73B$11.45B$12.73B
High Forecast$6.46B$9.30B$5.63B$7.19B$8.44B$9.28B$10.55B$12.19B$12.95B
Low Forecast$4.31B$8.99B$3.76B$4.80B$8.34B$8.76B$8.91B$10.72B$12.50B
Surprise %18.43%-15.43%48.01%--24.49%----

TMO Forecast FAQ

Is Thermo Fisher Scientific stock a buy?

Thermo Fisher Scientific stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 34 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Thermo Fisher Scientific is a favorable investment for most analysts.

What is Thermo Fisher Scientific's price target?

Thermo Fisher Scientific's price target, set by 41 Wall Street analysts, averages $592 over the next 12 months. The price target range spans from $460 at the low end to $693 at the high end, suggesting a potential 22.07% change from the previous closing price of $484.96.

How does Thermo Fisher Scientific stock forecast compare to its benchmarks?

Thermo Fisher Scientific's stock forecast shows a 22.07% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and outperforming the diagnostics & research stocks industry (14.86%).

What is the breakdown of analyst ratings for Thermo Fisher Scientific over the past three months?

  • July 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 22.58% Strong Buy, 58.06% Buy, 19.35% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 22.58% Strong Buy, 58.06% Buy, 19.35% Hold, 0% Sell, 0% Strong Sell.

What is Thermo Fisher Scientific’s EPS forecast?

Thermo Fisher Scientific's average annual EPS forecast for its fiscal year ending in December 2025 is $23.08, marking a 39.20% increase from the reported $16.58 in 2024. Estimates for the following years are $25.67 in 2026, $29.52 in 2027, and $32.82 in 2028.

What is Thermo Fisher Scientific’s revenue forecast?

Thermo Fisher Scientific's average annual revenue forecast for its fiscal year ending in December 2025 is $44.51B, reflecting a 3.81% increase from the reported $42.88B in 2024. The forecast for 2026 is $47.71B, followed by $51.15B for 2027, and $53.89B for 2028.

What is Thermo Fisher Scientific’s net income forecast?

Thermo Fisher Scientific's net income forecast for the fiscal year ending in December 2025 stands at $9.02B, representing an 42.42% increase from the reported $6.34B in 2024. Projections indicate $9.73B in 2026, $11.45B in 2027, and $12.73B in 2028.